key: cord-0819537-mr34sgbr
authors: Klingen, Robin L.; Katschinski, Benjamin; Anastasiou, Olympia E.; Stefan Ross, R.; Dittmer, Ulf; Le‐Trilling, Vu Thuy Khanh; Trilling, Mirko
title: Over 90% of clinical swabs used for SARS‐CoV‐2 diagnostics contain sufficient nucleic acid concentrations
date: 2020-12-02
journal: J Med Virol
DOI: 10.1002/jmv.26706
sha: b7dd89b9c882f9963a013bc3720b3382c1a884f6
doc_id: 819537
cord_uid: mr34sgbr

During the COVID‐19 pandemic caused by SARS‐CoV‐2, reliable diagnostics are absolutely indispensable. Molecular SARS‐CoV‐2 diagnostics based on nucleic acids (NA) derived from oro‐ or nasopharyngeal swabs constitute the current gold standard. Given the importance of test results, it is crucial to assess the quality of the underlying swab samples and NA extraction procedures. We determined NA concentrations in clinical samples used for SARS‐CoV‐2 testing applying an NA‐specific dye. In comparison to cut‐offs defined by SARS‐CoV‐2‐positive samples, internal positive controls, and references from a federal laboratory, 90.85% (923 of 1016) of swabs contained NA concentrations enabling SARS‐CoV‐2 recognition. Swabs collected by local health authorities and the central emergency department either had significantly higher NA concentrations or were less likely to exhibit insufficient quality, arguing in favor of sampling centers with routined personnel. Interestingly, samples taken from females had significantly higher NA concentrations than those from males. Among eight longitudinal patient sample sets with intermitting negative RT‐qPCR results, two showed reduced NA concentrations in negative specimens. The herein described fluorescence‐based NA quantification approach is immediately applicable to evaluate swab qualities, optimize sampling strategies, identify patient‐specific differences, and explain some peculiar test results including intermittent negative samples with low NA concentrations. This article is protected by copyright. All rights reserved.

report showed that despite the presence of typical COVID-19 symptoms, two swabs of the same patient tested negative for SARS-CoV-2 before the clinical manifestation was confirmed by bronchoalveolar lavage (BAL) sampling that tested positive 19 . Given the clinical, political, and socio-economic consequences and implications of such test results, it is of utmost importance to critically assess and continuously optimize sampling and diagnostic procedures.

In principle, one can use various types of clinical specimens for RT-qPCR diagnostics such as swabs from naso-or oropharyngeal areas, sputum, stool, saliva, and BAL 20 . Although recent reports discussed the potential of testing saliva samples 21, 22 , swabs are the most popular method used to acquire clinical specimens for routine diagnostics 23 . RT-qPCR primer pairs targeting different viral genes are in use. Typically, genes encoding the envelope (E), the spike (S), the membrane (M), the RNA-dependent RNA polymerase (RdRP), or the nucleocapsid (N) protein are recognized by the primers and probes 24 . To minimize the rate of false-positive results, at least two, sometimes even three, viral genes are assessed to increase the test specificity 12 . Commercial tests usually include PCR-based amplification controls based on an exogenously added NA molecule and the corresponding primers to eliminate false-negative results based on PCR-inhibiting contaminations. One way to determine the quality of samples and RT-qPCR test results is to quantify a human housekeeping gene as internal references 25, 26 .

However, since the availability of PCR test reagents is limited and the number of possible targets is restricted in most diagnostics devices, we aimed for an alternative approach to assess the quality of clinical specimens. To this end, we evaluated swab-derived eluates applying a fluorescence-based quantification of NA concentrations.

Based on the continuous debate concerning the reliability and predictive value of SARS-CoV-2 tests and whether and how the quality of collected specimens might influence test performances, we aimed to implement a fast, cost-effective, and convenient NA quantification protocol. Given the limitations of various diagnostic RT-qPCR cyclers in of 22 This article is protected by copyright. All rights reserved.

terms of the capacity to multiplex more fluorescent probe sets, and the demand for parallel tests recognizing several respiratory viruses in addition to SARS-CoV-2 such as influenza viruses, we opted against an additional RT-qPCR primer set identifying a housekeeping gene. Instead, we set out to quantify the overall NA concentration using the commercially available RNA-specific dye QuantiFluor combined with a set of well-defined RNA concentration standards as calibrators (see Materials and Methods section for details). As expected, the measured fluorescence intensities correlated very well with known RNA concentrations ( Fig. 1 After the successful establishment of the NA quantification method, we determined nucleic acid concentrations in a comprehensive set of clinical specimens submitted to our routine diagnostics department for RT-qPCR-based SARS-CoV-2 testing. All samples had been of 22 This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.

had a NA concentration below this lowest cut-off ( Fig. 2A) . Even if the least stringent lower cut-off value is applied as a reference, 90.85% of negative samples exhibited NA concentrations that would have allowed an RT-qPCR-based SARS-CoV-2 recognition as judged by positive results in parallel tests. The NA concentrations of the SARS-CoV-2-positive swabs were in a narrow range (~3-39 ng/µl; ~13-fold difference).

Assuming an optimal 2-fold amplification per PCR cycle, a 13-fold difference corresponds to ~3.7 CT values. Given that the actual CT values ranged from 12 to 44, NA concentrations in the specimen can only influence the quantitative result within narrow boundaries.

Accordingly, we neither found a significant correlation of the NA concentrations with the CT values determined by RT-qPCRs for the S (r 2 = 0.024; p = 0.06) nor for the E gene (r 2 = 0.019; p = 0.092) (Suppl. Fig. 1 ), suggesting that an NA quantification method can identify samples with insufficient NA concentrations but is not able to predict viral loads, which are influenced by numerous factors such as the patient's individual susceptibility, the therapy, and the course of disease.

We stratified the samples by criteria such as age, sex, and sample origin to evaluate donor-specific differences. Age groups were assigned according to the grouping used by Germany's federal disease control and prevention agency, the Robert Koch Institute (RKI), for example on its COVID-19 dashboard 28 . We did not find a correlation between patient age and NA concentrations in swab-derived samples (Pearson's r = 0.097; data not shown).

The rate of samples with less NA than 2.93 ng/µl ranged from 0 to 13.13% in different age groups (Fig. 2B) .

Although no statistical significance was reached in the individual age cohorts, all groups showed a trend towards higher average NA concentrations in swab samples obtained from female patients as compared to male patients in the same age group (Fig. 2B) . However, when we compared all samples derived from males and females against each other to evaluate potential sex-related differences concerning NA concentrations in swab samples, we observed a significantly (p=0.03) higher median nucleic acid concentration in samples of 22 This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.

There is an ongoing debate concerning the occurrence and potential reasons for longitudinal sample series derived from one patient that shows intermittent SARS-CoV-2-negative results. Such results have either been attributed to a viral recurrence (see, e.g., 29 (Fig. 3A-D) , NA concentrations in the SARS-CoV-2-negative samples were only slightly lower than in the adjacent samples tested positive, suggesting that improper swab sampling or NA extraction fail to explain these intermittent negative results. However, in several sample series, an apparent similarity between the slope of SARS-CoV-2 detection and NA concentrations became apparent (Fig. 3E-G) . In one infection course (Fig. 3E) , one negative tested sample had a much lower NA concentration than the other samples. Courses G and H both had three samples tested during a period of 8 to 12 days, with the middle sample being SARS-CoV-2-negative. In both cases, the negative tested eluate had a much lower NA concentration. In one course (Fig. 3H) , the SARS-CoV-2-negative sample on day 7 even exhibited a NA concentration (2.75 ng/µl) below the lower cut-off of 2.93 ng/µl, indicating of 22 This article is protected by copyright. All rights reserved.

that it would have been extremely difficult to detect SARS-CoV-2 based on such a low NA concentration in the swab-derived eluate. Thus, the herein described approach allows the identification of samples with NA concentrations insufficient for reliable SARS-CoV-2 diagnostics. This article is protected by copyright. All rights reserved.

and kits are used globally, we assume that our findings can be extrapolated to other regions.

In this case, 45.75 million tests worldwide may have been performed using inappropriate clinical specimens so far and approximately 366,000 are added daily. Since we observed significantly higher quality swabs from the local health authorities and the emergency department with lower proportions of insufficient samples and higher median NA concentrations, these data highlight an opportunity for optimization. They argue in favor of centralized institutions at which swabs are collected by personnel with continuous routine.

Such institutions should be well-connected to the actual test laboratory where the NA extraction and RT-qPCR are performed. Thereby time between sampling and testing is minimized as longer layover times may correlate with degeneration of free NAs and increased chances of bacterial or fungal contaminations, reducing swab quality 33 .

There is a similar number of laboratory-confirmed cases in both sexes in Germany 34 . It has been reported that female patients might be more prone to SARS-CoV-2 infections since the host entry receptor ACE2 is encoded on the X chromosome 35-37 . However, upon SARS-CoV-2 acquisition, the course of COVID-19 is known to be more severe in men than in women and sex hormones are considered to play a role in these sex-specific differences 38, 39 . Other risk factors such as obesity and smoking being more prevalent in men may also contribute. Further experiments will be necessary to explain the significant (p = 0.03) sex-related difference concerning NA concentrations in swab-based eluates between male and female patients herein described -to our knowledge-for the first time.

If NA concentrations of the eluate are not evaluated, a negative SARS-CoV-2 test can result either from the absence of an infection or the lack of sufficient test material. The fact that a considerable proportion (~10%) of eluates showed such low NA concentrations strongly advocates for implementing quality control measures for example by the herein described methodology. Otherwise, false-negative results may occur, which may postpone or prevent adequate antiviral therapy. In epidemiological surveillance programs, false-negative results of 22 This article is protected by copyright. All rights reserved.

can prevent the rapid identification of index cases and super-spreaders with catastrophic consequences for society.

Since NA quantification is fast and cost-effective, it can be used to save expensive and scarce RT-qPCR reagents and disposables. Especially during periods of limited supply and availability, reagents, disposables and sample slots in diagnostic devices should not be Taken together, the herein described fluorescence-based NA quantification approach is immediately applicable to evaluate swab qualities, optimize sampling strategies, identify patient-specific differences, and explain some peculiar test results such as intermittent negative samples.

Nucleic acids were extracted with the MagNaPure 96 large volume kit (Roche). NA was extracted from 500µl sample volume and eluted in 100µl elution buffer. A fraction of the eluate was used for direct virus detection using the RealStar® SARS-CoV-2 RT-PCR kit of 22 This article is protected by copyright. All rights reserved. 

An interactive web-based dashboard to track COVID-19

A Novel In-Cell ELISA Assay Allows Rapid and Automated Quantification of SARS-CoV-2 to Analyze Neutralizing Antibodies and Antiviral Compounds

Coronavirus Pandemic (COVID-19)

The Appropriate Use of Testing for COVID-19

Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction-Based SARS-CoV-2 Tests by Time Since Exposure

Negative Nasopharyngeal and Oropharyngeal Swabs Do Not Rule Out COVID-19

Korea Centers for Disease Control & Prevention. Findings from Investigation and analysis of re-positive cases

Diagnosis of COVID-19 by

Bronchoalveolar Lavage after Two Negative Nasopharyngeal Swabs

Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens for COVID-19

Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2

Saliva as a Candidate for COVID-19 Diagnostic Testing: A Meta-Analysis

Laboratory Diagnosis of COVID-19: 36

COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males?

Sex-Specific SARS-CoV-2 Mortality: Among Hormone-Modulated ACE2 Expression, Risk of Venous Thromboembolism and Hypovitaminosis D

Gender Differences in Patients With COVID-19: Focus on Severity and Mortality

Sexual Dimorphism of Coronavirus 19 Morbidity and Lethality

Positive RT-PCR Test Results in Patients Recovered From COVID-19

Recurrence of positive SARS-CoV-2 viral RNA in recovered COVID-19 patients during medical isolation observation

Discharged COVID-19 Patients

Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study

Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome

COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing

Genomic Evidence for a Case of Reinfection with SARS-CoV-2. SSRN

INSTAND Gesellschaft zur Förderung der Qualitätssicherung in medizinischen Laboratorien e.V. INSTAND e